Pay in 4 interest-free payments of $11.25 Learn more
Ships within 48 hours · Estimated delivery Jul 25 - Jul 30
SCR7 impedes tumor progression in mouse models
(1992) Proc Natl Acad Sci USA
It is the most widely used PI3K inhibitor to study the role of phosphoinositide 3-kinases in the signal transduction pathways involved in cell migration
74(13):3546-55
It impedes the formation of the Ubc13 and ubiquitin thioester conjugate and suppresses constitutive NF-κB activity in ABC-DLBCL cells
BI-9564 - BRD9 Bromodomain Inhibitor. CAS# 1883429-22-8 size:2 mg solid SCR7 impedes tumor progression inBI 9564, CAS No. 1883429 22 8, is a potent and selective inhibitor of BRD9 and BRD7 bromodomains (Kds = 14. 1 and 239 nM; IC50s = 75 nM and 3. 4 M, respectively). BI 9564 is useful in further exploring BRD9 bromodomain biology in both in vitro and in vivo settings. Selective inhibitors of bromodomain containing protein 9 (BRD9) may have therapeutic potential in the treatment of human malignancies and inflammatory diseases. Product information CAS
US$ 26.99
US$ 22.00
US$ 10.95
US$ 22.99